Challenges and Solutions for Allogeneic Cell Therapy Manufacturing

This poster reviews key process development considerations required to achieve robust, efficient, and scalable manufacturing of allogeneic cell therapies derived from pluripotent stem cells. The authors discuss major scale-up challenges including equipment selection, hydrodynamic control, oxygen transfer, medium exchange, and cell harvest operations. Case studies demonstrate how process optimization and Vertical-Wheel bioreactor technology can reduce seed train requirements, shorten manufacturing timelines, decrease facility footprint, and improve closed-system operation. The work also presents methodologies for maintaining consistent aggregate morphology through energy dissipation rate control, improving oxygen delivery using external oxygenation strategies, and developing scalable media exchange and harvest approaches. The poster highlights process-development principles that support commercial-scale manufacturing of iPSC-derived immune cell products.